Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 354 across all filing types
Latest filing 2020-09-28 Transaction in Own Shar…
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Boryung Pharmaceutical regarding the decision to extend a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). This type of filing, which details the company's decision to buy back its own shares through a trust, falls under the 'Transaction in Own Shares' category.
2020-09-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the sale of shares by an executive (Lee Jae-sul) of Boryung Pharmaceutical. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which falls under the 'Director's Dealing' category.
2020-09-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (e.g., Boryung Holdings and related individuals). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-09-22 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Boryung Pharmaceutical Co., Ltd. for the period ending June 30, 2020. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Boryung Pharmaceutical, detailing key financial metrics like revenue, operating profit, and net income for the second quarter of 2020. It provides a summary of financial highlights rather than a full annual or interim report. According to the filing definitions, an initial announcement of quarterly financial results is classified as an Earnings Release (ER). Q2 2020
2020-07-27 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a formal regulatory disclosure from Boryung Pharmaceutical regarding the acquisition of shares in another entity (Hayan I, L.P.). It details the acquisition amount, purpose, and board approval status. This type of disclosure, which involves corporate investment and capital allocation, is classified as a regulatory filing (RNS) as it does not fit into specific categories like M&A (which usually implies a merger or takeover of a business entity) or share issuance (SHA).
2020-06-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.